| 영문 | non-Hodgkin lymphoma | 한글 | 비호지킨 림프종 |
|---|---|---|---|
| 설명 | 림프종은 림프절에 생긴 악성 종양으로 백혈병과는 다르다. 백혈병은 골수에서 생긴 림프구성 악성종양이지만, 림프종은 림프조직에서 생긴 림프구성 악성종양이다. 크게 림프종은 2가지로 나눌 수 있는 데, 호지킨병(Hodgkin's lymphoma)과 비호지킨림프종(non-Hodgkin's lymphoma)으로 나눌 수 있다. 또한 비호지킨림프종은 여러 가지의 세포형태에 따라 나누고 있다. 이 병은 단지 림프절뿐만 아니라 지라, 골수, 이외 다른 기관을 침범함으로써 악성이며, 생명에 큰 위협을 준다. 악성림프종의 일종. 전이의 형태가 다양하여, 주위 림프절을 건너뛰어 다른 림프절로 전이하기도 한다. 또한 세포의 형태에 따라 여러 가지 종류가 있으며 대개 치료는 방사선치료와 화학요법을 복합하여 사용한다. |
||
| 영문 | lymphoma | 한글 | 림프종 |
|---|---|---|---|
| 설명 | 림프절에 생긴 악성 종양. 이 암은 백혈병과는 다르다. 림프성 백혈병은 골수에서 생긴 림프구성 악성종양이지만, 림프종은 림프절에서 생긴 림프구성 악성종양이다. 림프종은 크게 2가지 즉 호지킨림프종(Hodgkin's lymphoma)과 비호지킨림프종(Non-Hodgkin's lymphoma)으로 나눌수 있다. 또한 비호즈킨림프종은 여러 가지의 세포형태에 따라 나누고 있다. 이 병은 단지 림프절뿐만 아니라 지라, 골수, 이외 다른 기관을 침범함으로써 악성이며, 생명에 큰 위협을 준다. 특이한 형태로 버킷림프종(Burkitt's lymphoma)가 있다. 이 병은 주로 어린이에게 일어나며 주로 중앙 아프리카에 많이 발생한다. 또한 이 병은 바이러스(Ebstein Barr virus)에 의해서 일어나는 것으로 알려져 있다. 주된 침범부위는 얼굴의 아래턱뼈이다. |
||
| 영문 | Hodgkin's disease | 한글 | 호지킨병 |
|---|---|---|---|
| 설명 | 악성림프종의 한 형태이다. 호지킨병은 방사선 치료에 대단히 예민해서 충분한 양의 방사선으로 완전한 근치적 치료가 가능하다. |
||
| 영문 | ovarian cancer | 한글 | 난소암 |
|---|---|---|---|
| 설명 | 여성의 난소에 발생하는 암. 부인과종양으로서 50세 이상 여성악성종양의 약 18%를 차지한다. 종양은 대개 복부 깊숙히 위치하므로 종양이 많이 진행된 상태에서 발견되는 수가 많으며, 또한 종양의 초기에는 증상이 거의 없는 경우가 많아 더욱 조기발견이 어렵다. 아주 다양한 종류의 암이 발생하며, 예후도 각기 그 종양의 종류에 따라 다르다. 대표적인 암으로 장성낭샘암종(serous cystadenocarcinoma), 점액낭샘암종(mucinous cystadenocarcinoma), 종자세포종(germinoma 등이 있다. 치료는 수술적 치료가 선행되어야 하지만, 많이 진행되어 이미 다른 조직으로 전이가 이루어진 상태에서는 화학요법이 선택적으로 사용된다. |
||
| 영문 | cancer | 한글 | 암 |
|---|---|---|---|
| 설명 | 끝없이 분열을 하여 혈액이나 림프관을 통하여 다른 장기에까지 전파될 수 있는 세포의 덩어리. 즉 악성 신생물을 말한다. 신생물은 악성과 양성이 있는데, 악성일 경우에는 성장이 매우 빠르고 혈액이나 림프관을 통해서 멀리 다른 떨어진 장기로 암세포의 전파가 가능하여 다른 장기에도 암을 전이하며, 양성은 천천히 자라고 다른곳으로 전이가 생기지 않는다. 암은 암종과 육종의 두 가지로 나눌 수가 있다. 암종이란 상피세포의 과도한 증식에 의한 악성신생물을 이르는 말이고 육종이란 비상피성세포 특히 중간엽세포(발생당시에 중간엽에 해당하는 조직으로 발생후에 조직사이에 분포하면서 조직을 지지하는 역할을 하는 결합조직, 혈관, 림프관 등이 된다)의 과도한 증식에 의한 악성 신생물을 이르는 말이다. |
||
| HL | hairline; hairy leukoplakia; half life; hearing level; hearing loss; heparin lock; histiocytic lymph... |
|---|---|
| NHL | nodular histiocytic lymphoma; non-Hodgkin lymphoma |
| NHL | Non-Hodgkin's Lymphoma |
| NHML | non-Hodgkin malignant lymphoma |
| AFP | Alpha(α) Feto-Protein [HP 1826, 1858, 1859, 2265] ; Oncofetal Antigens &nbs... |
| B-NHL | B cell non Hodgkin's lymphoma |
|---|---|
| B-NHL | B non Hodgkin's lymphoma |
| NHL | Non Hodgkin Lymphoma |
| HL | Hodgkin lymphoma |
| LGNHL | Low-grade non-Hodgkin's lymphoma |
| cancer, lymphoma, hodgkin's | A type of lymphoma (cancer of the lymphatic system). The most common symptom of Hodgkin's disease is a painless swelling in the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment for Hodgkin's disease. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia. (12 Dec 1998) |
|---|
| cancer, lymphoma, non-hodgkin's | A lymphoma is a cancer that develops in the lymphatic system. The most common symptom of non-Hodgkin's lymphomas is a painless swelling in the lymph nodes in the neck, underarm, or groin. Non-Hodgkin's lymphomas are diagnosed with a biopsy of an enlarged lymph node. Follow-up examinations are important after lymphoma treatment. Most relapses occur in the first 2 years after therapy. (12 Dec 1998) |
|---|---|
| Hodgkin's lymphoma | <haematology, oncology> A human malgnant disorder of lymph tissue (lymphoma) that appears to originate in a particular lymph node and later spreads to the spleen, liver and bone marrow. It occurs mostly in individuals between the ages of 15 and 35. It is characterised by progressive, painless enlargement of the lymph nodes, spleen and general lymph tissue. Giant cells, the Reed Sternberg cells, with mirror image nuclei are diagnostic. Immunological depletion, caused perhaps by the excessive growth of neoplastic histiocytes, occurs. Four types of the disease are recognised depending on the relative predominance of various neoplastic derivatives of the lymphoid series. Pyrexia is often a feature of the disease. Death often results from generalised immunological inability to respond to infections. If detected early, it has a high remission rate. Staging: Ann Arbor classification; each stage is further classified as:, A no symptoms, B fever, sweats, weight loss. Stage I - involvement of a single lymph-node region or extralymphatic site. Stage II - two or more sites of involvement on the same side of the diaphragm. Stage III - disease involvement on both sides of the diaphragm. Stage IV - disseminated disease of extralymphatic organs, with or without lymph-node involvement. Indicence: approximately 1,500 new cases per year in the UK. (30 Mar 2000) |
| non-Hodgkin's lymphoma | <oncology, tumour> A group of lymphomas which differ in important ways from Hodgkin's disease and are classified according to the microscopic appearance of the cancer cells. The disease is classified as either low grade (slowly growing), intermediate grade or high grade (rapidly growing) and may be treated in a variety of ways depending on the exact diagnosis. Previously called lymphosarcoma. (30 Sep 1997) |
| lymphoma, non-hodgkin | Any of a group of malignant tumours of lymphoid tissue that differ from hodgkin disease, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumours is the absence of giant reed-sternberg cells, a characteristic of hodgkin's disease. (12 Dec 1998) |
| cancer, hodgkin's disease | A type of lymphoma (cancer of the lymphatic system). The most common symptom of Hodgkin's disease is a painless swelling in the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment for Hodgkin's disease. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia. (12 Dec 1998) |
| Goldman-Hodgkin-Katz equation | An equation derived to predict membrane potentials in terms of the membrane's permeability to ions and their concentrations on either side. Synonym: constant field equation, Goldman-Hodgkin-Katz equation, GHK equation. (05 Mar 2000) |
| Hodgkin, Alan | <person> British physiologist and Nobel laureate, *1914. See: Goldman-Hodgkin-Katz equation. (05 Mar 2000) |
| Hodgkin-Key murmur | <cardiology, clinical sign> A musical diastolic murmur associated with retroversion of an aortic cusp; often very loud. (05 Mar 2000) |
| Hodgkin's disease | <haematology, oncology> A human malgnant disorder of lymph tissue (lymphoma) that appears to originate in a particular lymph node and later spreads to the spleen, liver and bone marrow. It occurs mostly in individuals between the ages of 15 and 35. It is characterised by progressive, painless enlargement of the lymph nodes, spleen and general lymph tissue. Giant cells, the Reed Sternberg cells, with mirror image nuclei are diagnostic. Immunological depletion, caused perhaps by the excessive growth of neoplastic histiocytes, occurs. Four types of the disease are recognised depending on the relative predominance of various neoplastic derivatives of the lymphoid series. Pyrexia is often a feature of the disease. Death often results from generalised immunological inability to respond to infections. If detected early, it has a high remission rate. Staging: Ann Arbor classification; each stage is further classified as:, A no symptoms, B fever, sweats, weight loss. Stage I - involvement of a single lymph-node region or extralymphatic site. Stage II - two or more sites of involvement on the same side of the diaphragm. Stage III - disease involvement on both sides of the diaphragm. Stage IV - disseminated disease of extralymphatic organs, with or without lymph-node involvement. Indicence: approximately 1,500 new cases per year in the UK. (30 Mar 2000) |
| Hodgkin, Thomas | <person> British physician, 1798-1866. See: Hodgkin's disease, Hodgkin-Key murmur, non-Hodgkin's lymphoma. (05 Mar 2000) |
| disease, hodgkin's | A type of lymphoma (cancer of the lymphatic system). The most common symptom is painless swelling of the lymph nodes in the neck, underarm, or groin. Hodgkin's disease is diagnosed when abnormal tissue is detected by a pathologist after a biopsy of an enlarged lymph node. Treatment usually includes radiation therapy or chemotherapy. Regular follow-up examinations are important after treatment. Patients treated for Hodgkin's disease have an increased risk of developing other types of cancer later in life, especially leukaemia. A disease of the lymph nodes named after the English physician Thomas Hodgkin (1798-1866) who discovered it. (12 Dec 1998) |
| adult T-cell lymphoma | <tumour> An acute or subacute disease associated with a human T-cell virus, with lymphadenopathy, hepatosplenomegaly, skin lesions, peripheral blood involvement, and hypercalcaemia. Synonym: adult T-cell leukaemia. (05 Mar 2000) |
| anaplastic large cell lymphoma | <tumour> A form of lymphoma characterised by anaplasia of cells, sinusoidal growth, and immunoreactivity with CD30 (Ki-1 or Ber-H2). Synonym: Ki-1+ lymphoma. (05 Mar 2000) |
| benign lymphoma of the rectum | A rectal polyp composed of lymphoid tissue with follicle formation, covered by mucosa. (05 Mar 2000) |
| burkitt lymphoma | A form of undifferentiated malignant lymphoma usually found in central africa, but also reported in other parts of the world. It is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. B-cell antigens are expressed on the immature cells that make up the tumour in virtually all cases of burkitt lymphoma. The epstein-barr virus (herpes virus 4, human) has been isolated from burkitt lymphoma cases in africa and it is implicated as the causative agent in these cases; however, most non-african cases are ebv-negative. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|